4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-22-017159
Options or other derivatives
- CHIEF OPERATING OFFICER acquired 137,395 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jacobson Mark L. CHIEF OPERATING OFFICER | 2022-03-04 | Grant or award · Employee Stock Option (Right to Buy) | +89,405 | 89,405 | D | ||
| Jacobson Mark L. CHIEF OPERATING OFFICER | 2022-03-04 | Grant or award · Restricted Stock Units | +47,990 | 47,990 | D | ||
Loading xslF345X03/doc4.xml…